{"id":260,"date":"2021-12-09T11:24:20","date_gmt":"2021-12-09T11:24:20","guid":{"rendered":"https:\/\/tradingplatforms.com\/fr\/?page_id=260"},"modified":"2023-09-12T12:49:46","modified_gmt":"2023-09-12T12:49:46","slug":"actions-pharmaceutiques","status":"publish","type":"page","link":"https:\/\/tradingplatforms.com\/fr\/acheter-actions\/actions-pharmaceutiques\/","title":{"rendered":"Les meilleures actions pharmaceutiques \u00e0 acheter en 2025"},"content":{"rendered":"
Pharmaceutical companies are businesses focused on the research, development, manufacturing, and sale of drugs to treat diseases and conditions. Pharmaceutical stocks have seen a surge following the discovery of a vaccine for Covid-19.<\/span><\/span><\/p>\n This guide features some of the best pharmaceutical stocks to buy this year, and also the best brokers offering them.<\/span><\/span><\/p>\n You can invest in all these pharmaceutical stocks and many more on <\/span><\/span>eToro<\/span><\/span><\/strong> , our recommended stock broker!<\/span><\/span><\/p>\n Your capital is at risk. Other fees apply. For more information, visit etoro.com\/trading\/fees<\/span><\/span><\/em><\/p>\n Now let\u2019s see why the ten best pharmaceutical stocks we\u2019ve listed are worth including in your portfolio.<\/span><\/span><\/p>\n BioNTech (short for Biopharmaceutical New Technologies) develops and manufactures active immunotherapies to treat certain diseases in patients. Based in Mainz, Germany, BioNTech develops pharmaceutical products based on the principle of messenger ribonucleic acid (mRNA) for use in targeted cancer immunotherapies, protein replacement therapies for rare diseases, and cell engineering.<\/span><\/span><\/p>\n During the global pandemic, BioNTech partnered with American biotechnology giant Pfizer to manufacture its own Covid-19 vaccine. The partnership proved successful, as the Pfizer-BioNTech Covid-19 vaccine received regulatory approval with 95% efficacy in adults. This vaccine was recently approved for booster shots by the UAE Ministry of Health and Prevention. BNTX has had a stellar year so far. Starting the year at just over $100, BNTX reached a 52-week high of $463.14 on August 11 before falling back. It has been unable to re-attain its previous high since that plunge. However, BNTX stock has largely traded above the 20-day moving average (MA) with a value of $200 for most of the year.<\/span><\/span><\/p>\n Your capital is at risk. Other fees apply. For more information, visit etoro.com\/trading\/fees<\/span><\/span><\/em><\/p>\n Occupying a prominent position on the list of multinational biotechnology companies, JNJ is an American global company specializing in the manufacture of medical devices, pharmaceuticals, and consumer goods. However, JNJ derives most of its revenue from its pharmaceutical business, with immunology drugs Stelara and Tremfya and cancer treatments Darzalex and Erleada being its best-selling products.<\/span><\/span><\/p>\n The healthcare giant has been at the forefront of the fight against the Covid-19 pandemic with its single-dose Janssen vaccine. The product\u2019s appeal waned after side effects were detected earlier this year. However, Johnson & Johnson is still well positioned to profit from the pandemic, if the U.S. Food and Drug Administration (FDA) approves its product for the general American population.<\/span><\/span><\/p>\n Currently, Janssen has Emergency Use Authorization (EUA) for individuals 18 years of age and older. JNJ stock has been on an upward trend for most of this year. Starting at $153.49, JNJ jumped 15% to $170.34 in early January. Like many pharmaceutical stocks, JNJ peaked in mid-August and surged to $178.86, after hitting a low of $160.94 in June. At the time of publication, JNJ stock is trading in the red zone thanks to the company\u2019s efforts to get its Covid-19 vaccine approved.<\/span><\/span><\/p>\n Your capital is at risk. Other fees apply. For more information, visit etoro.com\/trading\/fees<\/span><\/span><\/em><\/p>\n Based in Massachusetts, USA, Moderna is a pharmaceutical and biotechnology giant focused on messenger RNA (mRNA) vaccination technologies. Moderna\u2019s technology inserts synthetic nucleoside-modified messenger RNA (modRNA) into cells.<\/span><\/span><\/p>\n The mRNA then reprograms cells to enable an immune response to external attacks. SpikeVax is approved by the US FDA for use in people aged 18 and older. With an efficacy of 94.1% in adults, SpikeVax has received approval from the European Medicines Agency (EMA) for adults and children aged 12 to 17.<\/span><\/span><\/p>\n MRNA stock has been one of the best-performing pharmaceutical stocks year-to-date. MRNA has averaged $200 in volatile markets after hitting $501.06 on August 10. MRNA has surged 264.44% this year, while its price-to-earnings (P\/E) ratio for the second quarter of 2021 was $6.46. Following a stock market decline, MRNA has tumbled 40% from its August high and is currently trading at $316.05.<\/span><\/span><\/p>\n Your capital is at risk. Other fees apply. For more information, visit etoro.com\/trading\/fees<\/span><\/span><\/em><\/p>\n Based in Maryland, USA, Novavax is a biotechnology company focused on developing vaccines to combat serious infectious diseases. Before the global outbreak of Covid-19, Novavax developed experimental vaccines against Ebola, influenza, respiratory syncytial virus (RSV), and several other viruses.<\/span><\/span><\/p>\n Like other companies, Novavax has been working on an experimental vaccine against this global pandemic. Still under review by the World Health Organization (WHO), Novavax\u2019s solution is expected to be the first Covid-19 protein subunit vaccine. Unlike other vaccines that need to be kept at sub-zero temperatures to remain effective, Novavax vaccines can be stored at normal refrigerated temperatures (2 to 8 degrees Celsius).<\/span><\/span><\/p>\n NVAX stock has been largely controlled by the whims of the market, with significant rallies and declines. The Maryland-based company started the year with a bang, reaching $331.16 before falling to $156 in early March. A subsequent rally took it to $264.72 the following month before plunging again to $117.86. Continuing its sporadic rise, NVAX jumped once more to $278.50 before falling back and finding support at $165.41.<\/span><\/span><\/p>\n Your capital is at risk. Other fees apply. For more information, visit etoro.com\/trading\/fees<\/span><\/span><\/em><\/p>\n Pfizer is one of the best pharmaceutical stocks on the market today. With high-performing drugs and medical devices such as Epipen, an epinephrine auto-injector, Depo-Provera, a birth control injection, and Dimetapp, a children\u2019s cough medicine, Pfizer has remained at the forefront of global drugs and medical devices since its founding in 1849.<\/span><\/span><\/p>\n The company boasts a large number of successful drugs that generate over $1 billion in annual revenue. This has allowed the company to increase its dividends over the past ten years. Thus, income-seeking investors have been able to obtain dividends exceeding 30% over the past five years. Joining the club of biotech companies in the fight against Covid-19, Pfizer has partnered with BioNTech to produce the Pfizer-BioNTech Covid-19 vaccine, which is marketed under the name Comirnaty.<\/span><\/span><\/p>\n The drug enjoyed tremendous success after its FDA approval for people 16 and older. A recent CDC authorization recommends booster shots for people over 18, six months after the first injection. Pfizer\u2019s stock rebounded a bit later than other pharmaceutical companies.<\/span><\/span><\/p>\n Trading at a moving average of $40, PFE stock reached a 52-week high of $51.96 on August 18, where it encountered resistance. A subsequent rally and plunge allowed PFE to retest the $51 threshold, but failed to break through. PFE lost steam and slowly slipped back towards the $40 area. At press time, PFE was trading below the 20-day moving average of $43.90 and trading at $41.93.<\/span><\/span><\/p>\nList of best pharmaceutical stocks 2025<\/h2>\n
\n
The best pharmaceutical stocks in detail<\/h2>\n
1. BioNTech \u2013 The Best Pharmaceutical Stock to Buy for Long-Term Gains<\/span><\/span><\/h3>\n
<\/p>\n
2. Johnson & Johnson (JNJ) \u2013 Best Pharmaceutical Stocks for Guaranteed Returns<\/span><\/span><\/h3>\n
<\/p>\n
3. Moderna \u2013 Best Pharmaceutical Stocks for Future Profit<\/span><\/span><\/h3>\n
<\/p>\n
4. Novavax \u2013 Best Pharmaceutical Company for Big Gains<\/span><\/span><\/h3>\n
<\/p>\n
5. Pfizer \u2013 A cheap pharmaceutical stock for under $50.<\/span><\/span><\/h3>\n
<\/p>\n